Wadsworth, IL, United States of America

Alford M Thomas


Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • Gurnee, IL (US) (1977)
  • Wadsworth, IL (US) (1981 - 1984)

Company Filing History:


Years Active: 1977-1984

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Journey of Alford M. Thomas

Introduction

Alford M. Thomas is a notable inventor based in Wadsworth, Illinois, whose contributions to the field of antibacterial agents have led to significant advancements in medical research and applications. With a total of five patents to his name, Thomas has focused on developing innovative solutions to combat bacterial infections.

Latest Patents

His latest patents reflect his extensive research and commitment to public health. One noteworthy invention is the use of Ristocetin .psi.-aglycone as an antibacterial agent, where he describes the efficacy of .psi.-aglycone and its derivatives in fighting bacterial infections. Additionally, his research on antibacterial peptides reveals that dipeptides containing a 3-fluoro-D-alanine N-terminus exhibit powerful antibacterial properties and produce a highly beneficial synergistic effect when combined with antibiotics.

Career Highlights

Thomas is currently employed at Abbott Laboratories Corporation, a leader in pharmaceuticals and medical devices. His work at Abbott has allowed him to contribute to groundbreaking research focusing on bacterial resistance and treatment modalities, which plays a crucial role in the ongoing fight against antibiotic-resistant bacteria.

Collaborations

Throughout his career, Alford M. Thomas has collaborated with esteemed colleagues, including Jerry R. Martin and Thomas R. Herrin. These partnerships have fostered innovative ideas and reinforced the importance of teamwork in scientific discovery.

Conclusion

Alford M. Thomas stands out as a pioneering inventor whose work continues to impact the field of antibacterial research. Through his patents and collaborations, he embodies the innovative spirit necessary to tackle contemporary challenges in medicine. His dedication to developing new antibacterial agents is essential in the ongoing efforts to improve healthcare outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…